NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · LARGE CAP
Alphatec Holdings, Inc. ATEC
17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$764.2M
▲ 25.0% vs FY2024
EPS · FY25
$-0.96
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
—
Net margin · FY25
-18.8%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 764.2M
Revenue, FY2025 · full 17-year series below
Revenue
Net income
The company lost 19 cents on every revenue dollar this year.
Per share
USD -0.96
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
—
Return on equity, FY2025
ROE
Operating margin-10.7%
Net margin-18.8%
Return on assets-18.3%
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+39.5% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+29.6%
+39.5%
+19.0%
+10.5%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.15B
Shares outstanding, FY2025
Change, 5 years+83.0%
Change, 10 years—
The share count grew 83% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 791.2M
total assets, end of FY2025
Total assetsUSD 791.2M
EquityUSD 12.4M
CashUSD 160.8M
Gross debtUSD 565.9M
Net debtUSD 405.1M
Current ratio2.06×
Net debt stands at 3260% of equity.
History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
0.8
0.6
0.5
0.4
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.2
0.2
0.2
0.1
Operating income $B
−0.1
−0.1
−0.2
−0.1
−0.1
−0.1
−0.0
−0.0
−0.0
−0.0
−0.2
0.0
−0.1
−0.0
−0.0
−0.0
−0.0
EBITDA $B
−0.0
−0.1
−0.1
−0.1
−0.1
−0.0
−0.0
−0.0
−0.0
−0.0
−0.2
0.0
−0.0
0.0
−0.0
0.0
0.0
Income tax $B
−0.0
0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
0.0
−0.0
−0.0
−0.0
0.0
Net income $B
−0.1
−0.2
−0.2
−0.2
−0.1
−0.1
−0.1
−0.0
−0.0
−0.0
−0.2
−0.0
−0.1
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
−0.96
−1.13
−1.54
−1.46
−1.49
−1.18
−1.09
−1.20
−1.08
−3.49
−21.53
−1.90
−0.85
−0.17
−0.25
−0.18
−0.27
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
·
−507.1
−859.1
−657.7
−135.9
−91.1
−186.3
·
·
·
−318.0
−8.0
−47.9
·
·
·
·
Shares out B
0.15
0.14
0.14
0.11
0.10
0.08
0.06
0.04
0.02
0.01
0.01
0.10
0.10
0.10
0.09
0.09
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
62 of 65
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 3 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed